RISDIPLAM
risdiplam 750 microgram/mL powder for oral liquid, 80 mL
RISDIPLAM (13659X)
13659X
Manner of administration:Oral
Restriction
Indication: Symptomatic type IIIB/IIIC spinal muscular atrophy (SMA)
Treatment phase: Continuing/maintenance treatment in a child or adult, but where treatment was initiated
during childhood
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 3 | Max qty units: 3 | # of repeats: 5 | DPMQ: $32,574.54 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Evrysdi | |||||